U.S. flag

An official website of the United States government

NM_000488.4(SERPINC1):c.1366G>C (p.Gly456Arg) AND Hereditary antithrombin deficiency

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Aug 2, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002664191.4

Allele description [Variation Report for NM_000488.4(SERPINC1):c.1366G>C (p.Gly456Arg)]

NM_000488.4(SERPINC1):c.1366G>C (p.Gly456Arg)

Gene:
SERPINC1:serpin family C member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q25.1
Genomic location:
Preferred name:
NM_000488.4(SERPINC1):c.1366G>C (p.Gly456Arg)
HGVS:
  • NC_000001.11:g.173903918C>G
  • NG_012462.1:g.18461G>C
  • NM_000488.4:c.1366G>CMANE SELECT
  • NM_001365052.2:c.1222G>C
  • NM_001386302.1:c.1489G>C
  • NM_001386303.1:c.1447G>C
  • NM_001386304.1:c.1345G>C
  • NM_001386305.1:c.1309G>C
  • NM_001386306.1:c.1150G>C
  • NP_000479.1:p.Gly456Arg
  • NP_000479.1:p.Gly456Arg
  • NP_001351981.1:p.Gly408Arg
  • NP_001373231.1:p.Gly497Arg
  • NP_001373232.1:p.Gly483Arg
  • NP_001373233.1:p.Gly449Arg
  • NP_001373234.1:p.Gly437Arg
  • NP_001373235.1:p.Gly384Arg
  • LRG_577t1:c.1366G>C
  • LRG_577:g.18461G>C
  • LRG_577p1:p.Gly456Arg
  • NC_000001.10:g.173873056C>G
  • NM_000488.3:c.1366G>C
Protein change:
G384R
Molecular consequence:
  • NM_000488.4:c.1366G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001365052.2:c.1222G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386302.1:c.1489G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386303.1:c.1447G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386304.1:c.1345G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386305.1:c.1309G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386306.1:c.1150G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary antithrombin deficiency (AT3D)
Synonyms:
Antithrombin III deficiency; Thrombophilia due to antithrombin III deficiency; Reduced antithrombin III activity; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0013144; MedGen: C0272375; OMIM: 613118; Human Phenotype Ontology: HP:0001976

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003523920Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(May 19, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV004099004Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Aug 2, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis.

Jochmans K, Lissens W, Vervoort R, Peeters S, De Waele M, Liebaers I.

Blood. 1994 Jan 1;83(1):146-51.

PubMed [citation]
PMID:
8274732

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003523920.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 456 of the SERPINC1 protein (p.Gly456Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with antithrombin deficiency (PMID: 8274732). It has also been observed to segregate with disease in related individuals. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center, SCV004099004.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

PS3, PM1, PM2, Pp1, PP3

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024